OSE Immunotherapeutics to Implement a Flexible Bridge Equity Financing
May 28, 2026 - 17:58
French biotech firm OSE Immunotherapeutics has announced a flexible bridge equity financing arrangement, marking the first step in a broader global financing strategy. The company is currently engaging with institutional investors in both the United States and Europe to support the initiative.
Based on the current share price, the gross proceeds from this financing could reach approximately 19.3 million euros over a 24-month period. The company expects this capital to extend its cash runway through to the end of December 2026.
As part of the updated financial timeline, OSE Immunotherapeutics has rescheduled the filing of its 2025 Universal Registration Document. The document, which will now include details of this financing, is expected to be filed on June 3, 2026.
The announcement was made by the company, which is headquartered in Nantes, France, on May 28, 2026. OSE Immunotherapeutics is listed on the Euronext Paris market.
MORE NEWS
July 12, 2026 - 19:10
Can Nvidia Still Turn Long-Term Investors Into Millionaires?Nvidia has already minted a generation of millionaires. Investors who bought the stock five years ago have seen gains of over 2,000%, turning a modest $10,000 stake into more than $200,000. But the...
July 12, 2026 - 04:45
Paramount–Warner Bros. merger could make HBO Max a 'staple'Wall Street is still waiting for the Paramount and Warner Bros. Discovery merger to close, but analysts are already betting on how the combined company will reshape the streaming landscape....
July 11, 2026 - 08:53
$9.5 Billion Focus Financial Network Expands to East Coast with Advisor Jennifer McDonaldMINNEAPOLIS, July 10, 2026 -- Focus Financial Network, a wealth management firm overseeing $9.5 billion in client assets, has expanded its footprint to the East Coast by adding financial advisor...
July 10, 2026 - 21:34
What the housing affordability bill means for buyers and sellersA new bipartisan bill in Congress, the 21st Century ROAD to Housing Act, is aiming to tackle the nation`s affordability crisis head-on. The legislation targets three main pain points: a severe...